Lucknow, India

Priti Tiwari

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2010.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Priti Tiwari: Innovator in Antidiabetic Compounds

Introduction

Priti Tiwari is a notable inventor based in Lucknow, India. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with antidiabetic properties. Her work focuses on creating innovative solutions to combat diabetes, a growing health concern worldwide.

Latest Patents

Priti Tiwari holds a patent for "Oxy substituted chalcones as antihyperglycemic and antidyslipidemic agents." This invention provides appropriately substituted chalcones, which are represented by a specific structural formula. The compounds exhibit significant antidiabetic effects in various animal models, indicating their potential for further exploitation in medical applications. She has 1 patent to her name.

Career Highlights

Throughout her career, Priti has demonstrated a strong commitment to research and innovation. Her work has contributed to the understanding of how certain chemical compounds can be utilized to manage diabetes effectively. She continues to explore new avenues in medicinal chemistry, aiming to improve health outcomes for patients.

Collaborations

Priti Tiwari has collaborated with notable colleagues, including Ram Pratap and Mavurapu Satyanarayana. These collaborations have enhanced her research efforts and contributed to the advancement of her innovative projects.

Conclusion

Priti Tiwari is a pioneering inventor whose work in developing antidiabetic compounds showcases her dedication to improving health through innovation. Her contributions to medicinal chemistry are significant and hold promise for future advancements in diabetes management.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…